Our study demonstrated that GAS5 was positively correlated with immune cell infiltration in NSCLC and it enhanced the recruitment of macrophages and T cells by activating type I interferon signaling pathway via MYBBP1A-p53/IRF1 axis in tumor cells. Here, GAS5 is linked to non-small cell lung carcinoma.